DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Scirica BM, Morrow DA, Hod H et al.
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non-ST-segment-elevation acute coronary syndrome.
Circulation 2007;
116: 1647-1652
We do not assume any responsibility for the contents of the web pages of other providers.